You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Screen for hepatitis B virus in all cancer patients starting systemic treatment. Find out more about hepatitis B virus screening and management.

Drug Formulary
About the Drug Formulary Email Drug Formulary Team

What’s New in the Drug Formulary

All new and recently updated drug and regimen monographs, patient information sheets, as well as safety and advice documents are available here.

Regimen
Published Date: 03 Jun 2024
Cancer Type:
Gastrointestinal, 
Neuroendocrine (GI)
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated PEBC guideline link

Updated
Jun 2024
Regimen
Published Date: 03 Jun 2024
Cancer Type:
Gastrointestinal, 
Neuroendocrine (GI), 
Lung, 
Neuroendocrine (Lung)
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated PEBC guideline link

Updated
Jun 2024
Regimen
Published Date: 03 Jun 2024
Cancer Type:
Gastrointestinal, 
Neuroendocrine (GI)
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Removed PEBC guideline link

Updated
Jun 2024
Regimen
Published Date: 03 Jun 2024
Cancer Type:
Gastrointestinal, 
Neuroendocrine (GI)
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated PEBC guideline link

Updated
Jun 2024
Regimen
Published Date: 03 Jun 2024
Cancer Type:
Gastrointestinal, 
Neuroendocrine (GI)
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated PEBC guideline link

Updated
Jun 2024
Regimen
Published Date: 03 Jun 2024
Cancer Type:
Gastrointestinal, 
Neuroendocrine (GI)
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated PEBC guideline link

Updated
Jun 2024
Regimen
Published Date: 03 Jun 2024
Cancer Type:
Gastrointestinal, 
Neuroendocrine (GI), 
Lung, 
Neuroendocrine (Lung)
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated PEBC guideline link

Updated
Jun 2024
Regimen
Published Date: 03 Jun 2024
Cancer Type:
Gastrointestinal, 
Neuroendocrine (GI)
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Removed PEBC guideline link

Updated
Jun 2024
Regimen
Published Date: 03 Jun 2024
Cancer Type:
Gastrointestinal, 
Neuroendocrine (GI)
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Removed PEBC guideline link

Updated
Jun 2024
Drug

Published Date: 28 May 2024

Revision Summary:
Drug Monograph: Updated Adverse effects, Dose modifications, Pregnancy/lactation, and Monitoring sections
Patient Info Sheet EN: Revised/Updated information sheet
Patient Info Sheet FR: Updated/revised information sheet (Fiche d’information mise à jour/révisée)
May 2024
Regimen
Published Date: 24 May 2024
Cancer Type:
Gastrointestinal, 
Neuroendocrine (GI), 
Lung, 
Neuroendocrine (Lung)
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Modified Dosage in hepatic impairment, Dosage in renal impairment, Dosage in the elderly, Interactions, Administration, and Pregnancy/lactation sections

May 2024
Regimen
Published Date: 22 May 2024
Cancer Type:
Breast
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: updated to reflect NDFP funding for pembro

May 2024

Pages